We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 8th:
Akoya Biosciences, Inc. : This life-sciences technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.
Alpha Tau Medical Ltd. (DRTS - Free Report) : This clinical-stage oncology therapeutics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.2% over the last 60 days.
Trupanion, Inc. (TRUP - Free Report) : This company that engages in the business of medical insurance for cats and dogs has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.4% over the last 60 days.
Image: Bigstock
Best Momentum Stocks to Buy for January 8th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 8th:
Akoya Biosciences, Inc. : This life-sciences technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.
Akoya Biosciences, Inc. Price and Consensus
Akoya Biosciences, Inc. price-consensus-chart | Akoya Biosciences, Inc. Quote
Akoya’s shares gained 11.9% over the last three months compared with the S&P 500’s advance of 8%. The company possesses a Momentum Score of A.
Akoya Biosciences, Inc. Price
Akoya Biosciences, Inc. price | Akoya Biosciences, Inc. Quote
Alpha Tau Medical Ltd. (DRTS - Free Report) : This clinical-stage oncology therapeutics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.2% over the last 60 days.
Alpha Tau Medical Ltd. Price and Consensus
Alpha Tau Medical Ltd. price-consensus-chart | Alpha Tau Medical Ltd. Quote
Alpha Tau’s shares gained 3.6% over the last month compared with the S&P 500’s advance of 1.7%. The company possesses a Momentum Score of B.
Alpha Tau Medical Ltd. Price
Alpha Tau Medical Ltd. price | Alpha Tau Medical Ltd. Quote
Trupanion, Inc. (TRUP - Free Report) : This company that engages in the business of medical insurance for cats and dogs has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.4% over the last 60 days.
Trupanion, Inc. Price and Consensus
Trupanion, Inc. price-consensus-chart | Trupanion, Inc. Quote
Trupanion’s shares gained 8.7% over the last three months compared with the S&P 500’s advance of 8%. The company possesses a Momentum Score of B.
Trupanion, Inc. Price
Trupanion, Inc. price | Trupanion, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.